{
  "release_id": "f6f6f1b6f50379ed",
  "id": "cardio:eliquis",
  "owner": "cardio",
  "kind": "product",
  "slug": "eliquis",
  "name": "Apixaban (Eliquis)",
  "aliases": [
    "Eliquis"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "The Eliquis brand of apixaban, whose FDA application names Bristol-Myers Squibb. The US Food and Drug Administration approved it in December 2012 to lower the stroke and systemic embolism risk of people with nonvalvular atrial fibrillation.",
  "summary_technical": "FDA NDA 202155, approved 2012-12-28 (approval letter), sponsor Bristol Myers Squibb in the openFDA record. openFDA lists tablets and tablets for oral suspension. The approval letter covers tablets of 2.5 mg and 5 mg. The openFDA record names no manufacturer, and this page links no company record.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-10-14",
  "last_evidence_check": "2026-10-14",
  "next_review_due": null,
  "identifiers": [],
  "navigation": {
    "cardio": {
      "condition-area": [
        "arrhythmias",
        "stroke"
      ]
    }
  },
  "payload": {
    "subtype": "medicine",
    "model_or_formulation": "Oral tablets and tablets for oral suspension (openFDA product list)",
    "version": "Original approval covered tablets of 2.5 mg and 5 mg (approval letter); later strengths and forms are not described here",
    "intended_use_snapshots": []
  },
  "content_digest": "a08167bd24541ba3bc64ae09a223d4783385956053b0accca5b8c958f572737b",
  "review": {
    "content_digest": "a08167bd24541ba3bc64ae09a223d4783385956053b0accca5b8c958f572737b",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "f6f6f1b6f50379ed",
      "id": "cardio:claim-fda-nda202155-approval",
      "owner": "cardio",
      "subject_entity_id": "cardio:eliquis",
      "category": "regulatory",
      "statement": "The US Food and Drug Administration approved NDA 202155 for ELIQUIS (apixaban) tablets of 2.5 mg and 5 mg, submitted by Bristol-Myers Squibb, on 28 December 2012. The approval letter states the indication as lowering the stroke and systemic embolism risk of people with nonvalvular atrial fibrillation. The openFDA record lists the original submission as approved, with priority review, in the class Type 1 - New Molecular Entity.",
      "context": {
        "id": "cardio:ctx-fda-nda202155-us-approval",
        "label": "United States NDA NDA202155 approval for ELIQUIS (apixaban)",
        "recipient": "unknown",
        "population": "People with nonvalvular atrial fibrillation (restated from the approval letter). The letter gives no other population details.",
        "care_setting": "Not stated in the FDA records",
        "geography": "United States (decision by the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the FDA records (they say people with atrial fibrillation and give no age)",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (regulatory decision)",
        "eligibility": {
          "inclusion": [],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "The approval letter and the openFDA record state the regulatory decision and the indication, not how well the medicine works for any person. The trial evidence is on the apixaban page (ARISTOTLE). The letter covers the tablets of 2.5 mg and 5 mg named in it, and later supplements and other product forms are not described here. openFDA data are unvalidated. The approval letter is a cite-only source until the integration owner confirms the terms for its host.",
      "editorial_state": "draft",
      "checked_at": "2026-10-14",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].application_number",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].sponsor_name",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].products[0].brand_name",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[4].submission_status",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[4].submission_class_code_description",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[4].review_priority",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:20:43Z",
            "content_hash": "4d13d5dc7f73a9a15c48573a0ba3a3bea9a54785a8f85d84fb19e5c8512cddec",
            "source_effective_date": "2026-10-13",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda202155",
            "source_type": "regulator",
            "title": "FDA drug application NDA202155 (openFDA Drugs@FDA record)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:NDA202155&limit=1",
            "identifiers": [
              {
                "scheme": "fda-nda",
                "value": "NDA202155",
                "normalized_value": "NDA202155",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drugsfda record returned on 2026-10-14, from a dataset last updated 2026-10-13.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-14 as cf-openfda-license.html, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2). The raw record is committed at research/snapshots/cf-openfda-drugsfda-NDA202155.json. It includes contact, address and registration fields that FDA publishes; records here do not repeat them.",
            "public_text": "quote"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Signature page, date (MM/DD/YYYY)",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:fda-letter-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:25:05Z",
            "content_hash": "f865fec50b4a9a4d2267f85e5b1d949e6b3669618910552d2640f14883e0c011",
            "source_effective_date": "2012-12-28",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:fda-letter-nda202155",
            "source_type": "regulator",
            "title": "FDA approval letter for NDA NDA202155",
            "canonical_url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration",
            "edition": "Approval letter PDF as fetched on 2026-10-14; the signature page is dated 2012-12-28.",
            "reuse_basis": "FDA approval letter hosted on accessdata.fda.gov, fetched as cf-fda-letter-NDA202155.pdf. Only the hash is kept. FDA's website policy page (fetched 2026-10-14 as cf-fda-website-policies.html, sha256 59b7c85417532ac45d5c62ed35646d399324edfc2cee023684995302e4eeb9b3) says the contents of www.fda.gov are in the public domain. This document is on the FDA database host, accessdata.fda.gov, which the policy page does not name, so the terms for this host are unverified and public text is cite_only until the integration owner confirms them.",
            "public_text": "cite_only"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Page 1, paragraph 2",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:fda-letter-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:25:05Z",
            "content_hash": "f865fec50b4a9a4d2267f85e5b1d949e6b3669618910552d2640f14883e0c011",
            "source_effective_date": "2012-12-28",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:fda-letter-nda202155",
            "source_type": "regulator",
            "title": "FDA approval letter for NDA NDA202155",
            "canonical_url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration",
            "edition": "Approval letter PDF as fetched on 2026-10-14; the signature page is dated 2012-12-28.",
            "reuse_basis": "FDA approval letter hosted on accessdata.fda.gov, fetched as cf-fda-letter-NDA202155.pdf. Only the hash is kept. FDA's website policy page (fetched 2026-10-14 as cf-fda-website-policies.html, sha256 59b7c85417532ac45d5c62ed35646d399324edfc2cee023684995302e4eeb9b3) says the contents of www.fda.gov are in the public domain. This document is on the FDA database host, accessdata.fda.gov, which the policy page does not name, so the terms for this host are unverified and public text is cite_only until the integration owner confirms them.",
            "public_text": "cite_only"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Page 1, addressee",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:fda-letter-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:25:05Z",
            "content_hash": "f865fec50b4a9a4d2267f85e5b1d949e6b3669618910552d2640f14883e0c011",
            "source_effective_date": "2012-12-28",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:fda-letter-nda202155",
            "source_type": "regulator",
            "title": "FDA approval letter for NDA NDA202155",
            "canonical_url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration",
            "edition": "Approval letter PDF as fetched on 2026-10-14; the signature page is dated 2012-12-28.",
            "reuse_basis": "FDA approval letter hosted on accessdata.fda.gov, fetched as cf-fda-letter-NDA202155.pdf. Only the hash is kept. FDA's website policy page (fetched 2026-10-14 as cf-fda-website-policies.html, sha256 59b7c85417532ac45d5c62ed35646d399324edfc2cee023684995302e4eeb9b3) says the contents of www.fda.gov are in the public domain. This document is on the FDA database host, accessdata.fda.gov, which the policy page does not name, so the terms for this host are unverified and public text is cite_only until the integration owner confirms them.",
            "public_text": "cite_only"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Page 1, paragraph 5",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:fda-letter-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:25:05Z",
            "content_hash": "f865fec50b4a9a4d2267f85e5b1d949e6b3669618910552d2640f14883e0c011",
            "source_effective_date": "2012-12-28",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:fda-letter-nda202155",
            "source_type": "regulator",
            "title": "FDA approval letter for NDA NDA202155",
            "canonical_url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration",
            "edition": "Approval letter PDF as fetched on 2026-10-14; the signature page is dated 2012-12-28.",
            "reuse_basis": "FDA approval letter hosted on accessdata.fda.gov, fetched as cf-fda-letter-NDA202155.pdf. Only the hash is kept. FDA's website policy page (fetched 2026-10-14 as cf-fda-website-policies.html, sha256 59b7c85417532ac45d5c62ed35646d399324edfc2cee023684995302e4eeb9b3) says the contents of www.fda.gov are in the public domain. This document is on the FDA database host, accessdata.fda.gov, which the policy page does not name, so the terms for this host are unverified and public text is cite_only until the integration owner confirms them.",
            "public_text": "cite_only"
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Page 1, indication",
          "applicability_note": "Quote from the FDA record.",
          "snapshot": {
            "id": "cardio:fda-letter-nda202155-2026-10-14",
            "retrieved_at": "2026-10-14T18:25:05Z",
            "content_hash": "f865fec50b4a9a4d2267f85e5b1d949e6b3669618910552d2640f14883e0c011",
            "source_effective_date": "2012-12-28",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:fda-letter-nda202155",
            "source_type": "regulator",
            "title": "FDA approval letter for NDA NDA202155",
            "canonical_url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202155Orig1s000ltr.pdf",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration",
            "edition": "Approval letter PDF as fetched on 2026-10-14; the signature page is dated 2012-12-28.",
            "reuse_basis": "FDA approval letter hosted on accessdata.fda.gov, fetched as cf-fda-letter-NDA202155.pdf. Only the hash is kept. FDA's website policy page (fetched 2026-10-14 as cf-fda-website-policies.html, sha256 59b7c85417532ac45d5c62ed35646d399324edfc2cee023684995302e4eeb9b3) says the contents of www.fda.gov are in the public domain. This document is on the FDA database host, accessdata.fda.gov, which the policy page does not name, so the terms for this host are unverified and public text is cite_only until the integration owner confirms them.",
            "public_text": "cite_only"
          }
        }
      ],
      "review": {
        "content_digest": "332111c8cbc3d322cda0184a770aa5309a812770647ae136d85e20814986016c",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-nda202155-approval.json"
    }
  ],
  "decisions": [
    {
      "type": "regulatory_decision",
      "id": "cardio:regdec-fda-nda202155",
      "product_id": "cardio:eliquis",
      "product_version": "Tablets of 2.5 mg and 5 mg (approval letter)",
      "indication": "To lower the stroke and systemic embolism risk of people with nonvalvular atrial fibrillation (approval letter, restated)",
      "context_id": "cardio:ctx-fda-nda202155-us-approval",
      "jurisdictions": [
        "US"
      ],
      "jurisdiction_note": "United States",
      "authority_id": "core:fda",
      "decision_type": "approval",
      "recall_class": null,
      "submission_id": "NDA202155",
      "pathway": "nda",
      "product_code": null,
      "device_class": null,
      "decision_date": "2012-12-28",
      "valid_to": null,
      "claim_id": "cardio:claim-fda-nda202155-approval"
    }
  ],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "contains",
        "label": "Active ingredient",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:apixaban",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:openfda-drugsfda-nda202155-2026-10-14",
          "locator": "results[0].products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Filed under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "products/eliquis/",
  "context_path": "api/v1/context/cardio--eliquis.md"
}